DE69328135D1 - Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren - Google Patents

Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren

Info

Publication number
DE69328135D1
DE69328135D1 DE69328135T DE69328135T DE69328135D1 DE 69328135 D1 DE69328135 D1 DE 69328135D1 DE 69328135 T DE69328135 T DE 69328135T DE 69328135 T DE69328135 T DE 69328135T DE 69328135 D1 DE69328135 D1 DE 69328135D1
Authority
DE
Germany
Prior art keywords
rhesus
produce
cell lines
human monoclonal
monoclonal antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69328135T
Other languages
English (en)
Inventor
Roland Beliard
Ulf Bethke
Dominique Bourel
Ahmed Bouzidi
Herve Broly
Peter Byrne
Magali Holuigue
Michael Kloft
Detlef Rohm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest Pharma GmbH
AETSRN
Original Assignee
Biotest Pharma GmbH
AETSRN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9207893A external-priority patent/FR2692786B1/fr
Priority claimed from DE19924224357 external-priority patent/DE4224357C2/de
Application filed by Biotest Pharma GmbH, AETSRN filed Critical Biotest Pharma GmbH
Priority to DE69328135T priority Critical patent/DE69328135D1/de
Application granted granted Critical
Publication of DE69328135D1 publication Critical patent/DE69328135D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69328135T 1992-06-26 1993-06-22 Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren Expired - Lifetime DE69328135D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE69328135T DE69328135D1 (de) 1992-06-26 1993-06-22 Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9207893A FR2692786B1 (fr) 1992-06-26 1992-06-26 Anticorps monoclonaux humains anti-rhesus d et lignees cellulaires les produisant.
DE19924224357 DE4224357C2 (de) 1992-07-23 1992-07-23 Arzneimittel zur Prophylaxe von HDN, enthaltend menschliche monoclonale anti-Rhesus (D)-Antikörper
DE69328135T DE69328135D1 (de) 1992-06-26 1993-06-22 Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren

Publications (1)

Publication Number Publication Date
DE69328135D1 true DE69328135D1 (de) 2000-04-27

Family

ID=25916870

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69328135T Expired - Lifetime DE69328135D1 (de) 1992-06-26 1993-06-22 Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren

Country Status (12)

Country Link
US (1) US5851524A (de)
EP (1) EP0576093B1 (de)
AT (1) ATE191006T1 (de)
AU (1) AU678364B2 (de)
BR (1) BR9305557A (de)
CA (1) CA2116246A1 (de)
DE (1) DE69328135D1 (de)
FI (1) FI940811A (de)
HU (1) HUT68624A (de)
MX (1) MX9303839A (de)
PL (1) PL302438A1 (de)
WO (1) WO1994000561A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
FR2858235B1 (fr) 2003-07-31 2006-02-17 Lab Francais Du Fractionnement Utilisation d'anticorps optimises en adcc pour traiter les patients faibles repondeurs
FR2861078B1 (fr) * 2003-10-16 2007-09-21 Lab Francais Du Fractionnement NOUVELLES IgG3 UTILES POUR STIMULER LA PHAGOCYTOSE
EP1967529A1 (de) 2004-07-20 2008-09-10 Symphogen A/S Rekombinanter polyklonaler Anti-Rhesus-D-Antikörper und Herstellungsverfahren
ATE548657T1 (de) 2004-07-20 2012-03-15 Symphogen As Prozedur zur strukturellen charakterisierung rekombinanter polyclonaler proteine oder einer polyclonalen zelllinie
TWI391399B (zh) 2005-05-25 2013-04-01 Hoffmann La Roche 測定溶離多肽之鹽濃度之方法
JP5064558B2 (ja) 2007-06-01 2012-10-31 エフ.ホフマン−ラ ロシュ アーゲー 免疫グロブリン精製
CA2639003A1 (en) * 2008-08-20 2010-02-20 Canadian Blood Services Inhibition of fc.gamma.r-mediated phagocytosis with reduced immunoglobulin preparations
JP2012513425A (ja) 2008-12-22 2012-06-14 エフ.ホフマン−ラ ロシュ アーゲー 免疫グロブリンの精製
US20110059079A1 (en) * 2009-09-04 2011-03-10 Xoma Technology Ltd. Antibody Coformulations
WO2011028961A2 (en) 2009-09-04 2011-03-10 Xoma Technology Ltd. Anti-botulism antibody coformulations
CN106267405B (zh) * 2016-07-01 2019-02-19 翁炳焕 母胎血型不合溶血病治疗仪

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
GB8722018D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722019D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722020D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8906129D0 (en) * 1989-03-17 1989-05-04 Central Blood Lab Authority Pharmaceutical preparations

Also Published As

Publication number Publication date
HU9400862D0 (en) 1994-06-28
WO1994000561A1 (en) 1994-01-06
CA2116246A1 (en) 1994-01-06
FI940811A0 (fi) 1994-02-21
AU4419793A (en) 1994-01-24
EP0576093A1 (de) 1993-12-29
US5851524A (en) 1998-12-22
MX9303839A (es) 1994-08-31
ATE191006T1 (de) 2000-04-15
PL302438A1 (en) 1994-07-25
EP0576093B1 (de) 2000-03-22
HUT68624A (en) 1995-07-28
BR9305557A (pt) 1997-03-25
AU678364B2 (en) 1997-05-29
FI940811A (fi) 1994-02-21

Similar Documents

Publication Publication Date Title
NL300433I2 (en) Methods and compositions for the treatment of glomerulonephritis.
TR200002405T2 (tr) İnsan CD40' a karşı antikorlar
ATE191006T1 (de) Menschliche monoklonale antikörper gegen rhesus d und zellinien die diese produzieren
DE122004000036I1 (de) Therapeutische Verwendung von chimerischen und markierten Antik¦rper gegen menschlichen B Lymphozyt beschr{nkter Differenzierung antigen f}r die Behandlung von B-Zell-Lymphoma.
TW376320B (en) Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
DE69934515D1 (de) Humanisierte monoklonale integrin antikörper
MXPA05014152A (es) Anticuerpos dirigidos a los mutantes de delecion de receptor de factor de crecimiento epidermico y sus usos.
HK1008819A1 (en) Piperidine derivatives as neurokinin antagonists
CY1112447T1 (el) Ανθρωπινα αντισωματα για την ιντερλευκινη (ιντεrleukin) 15 (il-15)
MX9709238A (es) Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
AU7690596A (en) Anti-CD6 monoclonal antibodies and their uses
CY2198B1 (en) 1-Aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
SG48816A1 (en) Gonococcal anti-idiotypic antibodies and methods and compositions using them
DE69007799D1 (de) Pharmazeutische antigen-antikörper-komplexe enthaltende zusammensetzungen und deren anwendungen.
EP0493446A4 (en) Treatment of autoimmune disease
EP0339163A3 (en) Monoclonal antibodies specific for hiv and hybridomas for their production
DE59309133D1 (de) Granulozytenbindende Antikörperkonstrukte, ihre Herstellung und Verwendung
CA2070182A1 (en) Chimeric immunoglobulin for cd4 receptors
ATE254659T1 (de) Mikroorganismen, ihre herstellung und verwendung
IT1254705B (it) Anticorpi monoclonali specifici per il fattore neuronotrofico ciliare (cntf) umano ricombinante
GEP20043233B (en) Composition Containing Blocking Monoclonal Antibody VLA-1
HK1013296A1 (en) Analogs of thymosin alpha 1
AU6829396A (en) Compositions and their uses
MX9710002A (es) Nuevo uso medico.
MX9804579A (es) Composiciones que contienen bismuto para la prevencion y tratamiento de trastornos gastrointestinales.

Legal Events

Date Code Title Description
8332 No legal effect for de